FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Felipe García

Research Profile

Disorders

Living Beings

HIV-1

Concepts & Ideas

Procedures

Chemicals & Drugs

Anatomy

Geographic Areas

Spain

Physiology

Co-author Network

Publications

TOP 3
H Arberas; M E Bargalló; J L Blanco; M Calvo; Felipe García; José M Gatell; A C Guardo; María J Maleno; Montserrat Plana
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.
Alberto Crespo Guardo; María J Maleno; Beatriz Mothe; José Alcami; Carmen Alvarez-Fernández; Hodei Arberas; Manuel Enric Bargalló; Felipe García; Javier García-Pérez; José María Gatell; Sonsoles Sánchez-Palomino; Montserrat Plana
Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals.
Felipe García
'Functional cure' of HIV infection: the role of immunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Felipe García (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: H Arberas; M E Bargalló; J L Blanco; M Calvo; Felipe García; José M Gatell; A C Guardo; María J Maleno; Montserrat Plana
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.
The Journal of antimicrobial chemotherapy 2013;68(3):577-86.
2013: Alberto Crespo Guardo; María J Maleno; Beatriz Mothe; José Alcami; Carmen Alvarez-Fernández; Hodei Arberas; Manuel Enric Bargalló; Felipe García; Javier García-Pérez; José María Gatell; Sonsoles Sánchez-Palomino; Montserrat Plana
Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals.
PloS one 2013;8(3):e58927.
2012: Felipe García
'Functional cure' of HIV infection: the role of immunotherapy.
Immunotherapy 2012;4(3):245-8.
2012: Víctor Casanova; Nuria Climent; Rafael Franco; Teresa Gallart; Felipe García; José M Gatell; Carme Lluis; Josefa Mallol; Marta Massanella; Isaac Naval-Macabuhay; Marta Rodríguez-García; Julià Blanco; Peter J McCormick
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.
PloS one 2012;7(12):e51287.
2012: Carmen Álvarez-Fernández; Jose Alcamí; Julia Blanco; Alberto Crespo Guardo; Laura Escribà-García; Felipe García; Javier García-Pérez; Jose Maria Gatell; Montserrat Plana; Sonsoles Sánchez-Palomino
Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.
PloS one 2012;7(11):e48848.
2011: Felipe García; Juan García-Arriaza; José M Gatell; Carmen Elena Gómez; Nuria González; Alberto C Guardo; José Luis Jiménez; Victoria Jiménez; Agathe León; Peter Liljeström; María J Maleno; María Angeles Muñoz-Fernández; José Luis Nájera; Giuseppe Pantaleo; Beatriz Perdiguero; Iñaki Pérez; Judit Pich; Montserrat Plana; Jonathan Weber; José Alcamí; Amparo Alvarez; Joan Albert Arnaiz; Juan Carlos López Bernaldo de Quirós; Matilde Sánchez Conde; Vicens Díaz-Brito; Mariano Esteban
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Vaccine 2011;29(46):8309-16.
2011: Felipe García; Jean-Pierre Routy
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.
Vaccine 2011;29(38):6454-63.
2011: Cristina Gil; Carmen Hurtado; Agathe León; Jeffrey D Lifson; Javier Martinez-Picado; L Miralles; José M Miró; Sara Nieto-Márquez; Tomás Pumarola; Cristina Rovira; Laura Zamora; Manel Almela; Christian Brander; Nuria Climent; Bonaventura Clotet; Judith Dalmau; Teresa Gallart; Felipe García; M Teresa García; José M Gatell
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Vaccine 2011;29(34):5711-24.
2011: Sonsoles Sánchez-Palomino; Eloísa Yuste; José Alcamí; Margarita Bofill; Jorge Carrillo; Bonaventura Clotet; Ana García; Felipe García; Josep M Gatell; Nuria González; Marta Massanella; Alberto Merino; Julià Blanco
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
Vaccine 2011;29(32):5250-9.
2011: Nuria Climent; Susana Guerra; Felipe García; Cristina Rovira; Laia Miralles; Carmen Elena Gómez; Núria Piqué; Cristina Gil; José María Gatell; Mariano Esteban; Teresa Gallart
Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
PloS one 2011;6(5):e19644.
2010: Míriam J Alvarez-Martínez; José M Miró; Maria Eugenia Valls; Jordi Mas; Jorge Puig de la Bellacasa; Omar Sued; Manel Solé; Paula V Rivas; Elisa de Lazzari; Natividad Benito; Felipe García; Carlos Agustí; Paul E Wilson; José M Gatell; Maria Teresa Jiménez de Anta; Steven R Meshnick; Asunción Moreno
Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
Diagnostic microbiology and infectious disease 2010;68(1):60-5.
2010: Marta Rodríguez-García; Núria Climent; Harold Oliva; Víctor Casanova; Rafael Franco; Agathe Leon; José M Gatell; Felipe García; Teresa Gallart
Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.
PloS one 2010;5(2):e9436.
2009: Marta Rodríguez-García; Harold Oliva; Nuria Climent; Maria M Escribese; Felipe García; Thomas M Moran; José M Gatell; Teresa Gallart
Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.
Clinical immunology (Orlando, Fla.) 2009;131(3):374-84.
2009: Alba Ruiz; Meritxell Nomdedeu; Marisa Ortega; Marylène Lejeune; Javier Setoain; Nuria Climent; Emilio Fumero; Montserrat Plana; Agathe León; Llucia Alós; Carlos Piera; Francisco Lomeña; Jose M Gatell; Teresa Gallart; Felipe García
Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients.
Immunotherapy 2009;1(3):347-54.
2007: Marta Garrido; Anna Mozos; Antonio Martínez; Felipe García; Anna Serafín; Vanesa Morente; Miguel Caballero; Cristina Gil; Emilio Fumero; José M Miró; Nuria Climent; José M Gatell; Llucia Alos
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):268-74.
2007: Marta Rodríguez-García; Harold Oliva; Nuria Climent; Felipe García; José M Gatell; Teresa Gallart
Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3.
Journal of leukocyte biology 2007;82(5):1143-6.
2007: Anna Suy; Pedro Castro; Meritxell Nomdedeu; Felipe García; Anna López; Emilio Fumero; Teresa Gallart; Lucia Lopalco; Oriol Coll; José M Gatell; Montserrat Plana
Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
The Journal of infectious diseases 2007;196(8):1191-201.
2007: Pedro Castro; Montserrat Laguno; Meritxell Nomdedeu; Anna López; Montserrat Plana; Emilio Fumero; Teresa Gallart; Josep Mallolas; José M Gatell; Felipe García
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.
AIDS research and human retroviruses 2007;23(7):863-7.
2007: Esteban Martínez; Ana Milinkovic; E Buira; Elisa De Lazzari; Agathe León; María Larrousse; Montserrat Loncá; Montserrat Laguno; José L Blanco; Josep Mallolas; Felipe García; José M Miró; José M Gatell
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
HIV medicine 2007;8(4):251-8.
2006: Josep M Sierra; Francesca Sánchez; Pedro Castro; Margarita Salvadó; Gloria de la Red; Agnes Libois; Manel Almela; Francesca March; Montserrat Español; Maria Antonia Sambeat; Joan Romeu; M Teresa Brugal; Patricia García De Olalla; José M Gatell; Jordi Vila; Felipe García; José L López-Colomés; Joan A Caylà; Pere Coll
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Medicine 2006;85(3):139-46.
2006: Omar Sued; José M Miró; Aitor Alquezar; Xavier Claramonte; Felipe García; Montserrat Plana; Mireia Arnedo; Elisa De Lazzari; Cristina Gil; Christian Manzardo; José L Blanco; Esteban Martínez; Josep Mallolas; Joan Joseph; Tomás Pumarola; Teresa Gallart; José M Gatell
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
Enfermedades infecciosas y microbiología clínica 2006;24(4):238-44.
2005: Alex Soriano; Francisco Lozano; Harold Oliva; Felipe García; Meritxell Nomdedéu; Elisa De Lazzari; Carmen Rodríguez; Alicia Barrasa; José I Lorenzo; Jorge del Romero; Montserrat Plana; José M Miró; José M Gatell; Jordi Vives; Teresa Gallart
Polymorphisms in the interleukin-4 receptor alpha chain gene influence susceptibility to HIV-1 infection and its progression to AIDS.
Immunogenetics 2005;57(9):644-54.
2005: José L Blanco; M Alejandra Biglia; Mireia Arnedo; Esteban Martínez; Josep Mallolas; Ana Milinkovic; Montserrat Laguno; María Larrousse; Agathe Leon; Montserrat Lonca; Felipe García; José M Miró; Tomás Pumarola; José M Gatell
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.
AIDS (London, England) 2005;19(8):829-31.
2005: Felipe García; Marylène Lejeune; Nuria Climent; Cristina Gil; José Alcamí; Vanesa Morente; Llucia Alós; Alba Ruiz; Javier Setoain; Emilio Fumero; Pedro Castro; Anna López; Anna Cruceta; Carlos Piera; Eric Florence; Arturo Pereira; Agnes Libois; Nuria González; Meritxell Guilá; Miguel Caballero; Francisco Lomeña; Joan Joseph; José M Miró; Tomás Pumarola; Montserrat Plana; José M Gatell; Teresa Gallart
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.
The Journal of infectious diseases 2005;191(10):1680-5.
2005: Christian Manzardo; María Del Mar Ortega; Omar Sued; Felipe García; Asunción Moreno; José M Miró
Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era.
Journal of neurovirology 2005;11 Suppl 3():72-82.
2005: Montserrat Laguno; Ana Milinkovic; Elisa De Lazzari; Javier Murillas; Esteban Martínez; José L Blanco; Montserrat Loncá; Alejandra Biglia; Agathe Leon; Mercedes García; María Larrousse; Felipe García; José M Miró; José M Gatell; Josep Mallolas
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients.
Antiviral therapy 2005;10(3):423-9.
2005: Olga Millán; Mercè Brunet; Jaume Martorell; Felipe García; Elena Vidal; Isabel Rojo; Montserrat Plana; Teresa Gallart; Tomás Pumarola; José M Miró; José M Gatell
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.
Clinical pharmacokinetics 2005;44(5):525-38.
2005: Montserrat Laguno; José M Sánchez-Tapias; Javier Murillas; Xavier Forns; José L Blanco; Esteban Martínez; María Larrousse; Agathe León; Montserrat Loncá; Ana Milinkovic; José M Miró; Felipe García; José M Gatell; Josep Mallolas
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection].
Enfermedades infecciosas y microbiología clínica 2005;23(1):32-40.
2004: Montserrat Laguno; Jordi Blanch; Javier Murillas; José L Blanco; Agathe León; Montserrat Lonca; María Larrousse; Alejandra Biglia; Esteban Martinez; Felipe García; José M Miró; Joan de Pablo; José M Gatell; Josep Mallolas
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Antiviral therapy 2004;9(6):905-9.
2004: Felipe García; Montserrat Plana; Mireia Arnedo; Mercè Brunet; Pedro Castro; Cristina Gil; Elena Vidal; Olga Millán; Anna López; Jaume Martorell; Emilio Fumero; José M Miró; José Alcamí; Tomás Pumarola; Teresa Gallart; José M Gatell
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):823-30.
2004: Felipe García; Elisa De Lazzari; Montserrat Plana; Pedro Castro; Gabriel Mestre; Meritxell Nomdedeu; Emilio Fumero; Esteban Martínez; Josep Mallolas; José L Blanco; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
Journal of acquired immune deficiency syndromes (1999) 2004;36(2):702-13.
2004: Montserrat Plana; Elena Ferrer; Catalina Martínez; Daniel Podzamczer; Felipe García; María J Maleno; Juan J Barceló; Ana García; Maria J Barberá; Montserrat Lacarcel; José M Miró; Teresa Gallart; José M Gatell
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Antiviral therapy 2004;9(2):197-204.
2004: Emilio Fumero; Felipe García; José M Gatell
Immunosuppressive drugs as an adjuvant to HIV treatment.
The Journal of antimicrobial chemotherapy 2004;53(3):415-7.
2003: Pilar Navarrete; Vanesa Morente; Felipe García; Llucia Alós; Mireia Arnedo; Montserrat Plana; Cristina Gil; Miguel Caballero; José M Miró; Esteban Martínez; Emilio Fumero; Pedro Castro; José L Blanco; Josep Mallolas; Jordi Blanch; Anna Cruceta; Gabriel Mestre; Tomás Pumarola; Teresa Gallart; José M Gatell
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
Antiviral therapy 2003;8(6):635-7.
2003: Felipe García; Montserrat Plana; Mireia Arnedo; Gabriel M Ortiz; José M Miró; Lucia Lopalco; Franco Lori; Tomás Pumarola; Teresa Gallart; José M Gatell
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
AIDS (London, England) 2003;17(1):43-51.
2002: Carles Codina; Mireia Martínez; Montserrat Tuset; Elena del Cacho; María Teresa Martín; José M Miró; Josep Mallolas; Elisa De Lazzari; Felipe García; Esteban Martínez; José M Gatell; Josep Ribas
[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].
Enfermedades infecciosas y microbiología clínica 2002;20(10):484-90.
2002: Alex Soriano; Catalina Martínez; Felipe García; Montserrat Plana; Eduard Palou; Marylène Lejeune; Juan I Aróstegui; Elisa De Lazzari; Carmen Rodriguez; Alicia Barrasa; José I Lorenzo; José Alcamí; Jorge del Romero; José M Miró; José M Gatell; Teresa Gallart
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
The Journal of infectious diseases 2002;186(7):922-31.
2002: Felipe García; Montserrat Plana; Gabriel Mestre; Mireia Arnedo; Cristina Gil; José M Miró; Anna Cruceta; Tomás Pumarola; Teresa Gallart; José M Gatell
Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection.
AIDS (London, England) 2002;16(13):1761-5.
2002: Cecilia Tortajada; Bernardo Pérez-Cuevas; Asuncion Moreno; Esteban Martínez; Josep Mallolas; Felipe García; Eugenia Valls; José M Miró; Esther De Lazzari; José M Gatell
Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2002;30(3):364-6.
2002: Montserrat Plana; Catalina Martínez; Felipe García; María J Maleno; Juan J Barceló; Ana García; Marylène Lejeune; Carmen Vidal; Anna Cruceta; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):429-34.
2001: Esteban Martínez; Mireia Arnedo; Vicente Giner; Cristina Gil; Miguel Caballero; Llucia Alós; Felipe García; C Holtzer; Josep Mallolas; José M Miró; Tomás Pumarola; José M Gatell
Lymphoid tissue viral burden and duration of viral suppression in plasma.
AIDS (London, England) 2001;15(12):1477-82.
2001: Felipe García; Montserrat Plana; Gabriel M Ortiz; Sebastian Bonhoeffer; A Soriano; Carme Vidal; Anna Cruceta; Mireia Arnedo; Cristina Gil; G Pantaleo; Tomás Pumarola; Teresa Gallart; D F Nixon; José M Miró; José M Gatell
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection.
AIDS (London, England) 2001;15(9):F29-40.
2000: Felipe García; Hernando Knobel; Maria Antonia Sambeat; Julio Arrizabalaga; Miquel Aranda; Joan Romeu; David Dalmau; Ferran Segura; JL Gomez-Sirvent; Elena Ferrer; Anna Cruceta; Teresa Gallart; Tomás Pumarola; José M Miró; José M Gatell
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan study.
AIDS (London, England) 2000;14(16):2485-94.
2000: Montserrat Plana; Felipe García; Teresa Gallart; Cecilia Tortajada; Alex Soriano; Eduard Palou; María J Maleno; Juan J Barceló; C Vidal; Anna Cruceta; José M Miró; José M Gatell
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
AIDS (London, England) 2000;14(13):1921-33.
2000: Felipe García; M M Alonso; Joan Romeu; Hernando Knobel; Julio Arrizabalaga; Elena Ferrer; David Dalmau; I Ruiz; Francesc Vidal; A Frances; Ferran Segura; JL Gomez-Sirvent; Anna Cruceta; Bonaventura Clotet; Tomás Pumarola; Teresa Gallart; WA O'Brien; José M Miró; José M Gatell
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):26-35.
1999: Felipe García; Joan Romeu; Imma Grau; Maria Antonia Sambeat; David Dalmau; Hernando Knobel; JL Gomez-Sirvent; Julio Arrizabalaga; Anna Cruceta; Bonaventura Clotet; Daniel Podzamczer; Tomás Pumarola; Teresa Gallart; WA O'Brien; José M Miró; José M Gatell
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
AIDS (London, England) 1999;13(17):2377-88.
1999: Felipe García; G Niebla; Joan Romeu; Carme Vidal; Montserrat Plana; M Ortega; L Ruiz; Teresa Gallart; B Clotet; José M Miró; Tomás Pumarola; José M Gatell
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
AIDS (London, England) 1999;13(12):1491-6.
1999: Felipe García; Montserrat Plana; Carme Vidal; Anna Cruceta; WA O'Brien; G Pantaleo; Tomás Pumarola; Teresa Gallart; José M Miró; José M Gatell
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
AIDS (London, England) 1999;13(11):F79-86.
1999: Felipe García; Mireia Cebrián; Martinho Dgedge; Jordi Casademont; Josep Lluís Bedini; O Neves; Xavier Filella; M Cinta Cid; Manuel Corachán; Josep M Grau
Endothelial cell activation in muscle biopsy samples is related to clinical severity in human cerebral malaria.
The Journal of infectious diseases 1999;179(2):475-83.
1998: C Vidal; Felipe García; José M Gatell; M Leal; B Clotet; Tomás Pumarola; José M Miró; Josep Mallolas; L Ruiz; Anna Cruceta; Cecilia Tortajada
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):55-60.
1998: C Vidal; Felipe García; Joan Romeu; L Ruiz; José M Miró; Anna Cruceta; A Soriano; Tomás Pumarola; Bonaventura Clotet; José M Gatell
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection.
AIDS (London, England) 1998;12(11):1285-9.
1997: Felipe García; Carme Vidal; José M Gatell; José M Miró; A Soriano; Tomás Pumarola
Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
AIDS (London, England) 1997;11(1):53-7.